Morbus Behçet – a rare disease in Central Europe
暂无分享,去创建一个
[1] D. Valla,et al. Behcet’s disease in budd-chiari syndrome , 2013, Orphanet Journal of Rare Diseases.
[2] Queiroz,et al. The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.
[3] E. Cunningham,et al. Differential Diagnosis of Behçet Uveitis , 2013, Ocular immunology and inflammation.
[4] S. Bonin,et al. Analysis of Diagnostic Criteria in Adamantiades-Behçet Disease: A Retrospective Study , 2013, Indian journal of dermatology.
[5] F. Shahram,et al. Impact of the positive pathergy test on the performance of classification/diagnosis criteria for Behcet’s disease , 2013, Modern rheumatology.
[6] M. Liang,et al. Oral aphthosis: management gaps and recent advances. , 2012, Annals of the Academy of Medicine, Singapore.
[7] N. Shen,et al. Cytokines and Behcet's disease. , 2012, Autoimmunity reviews.
[8] M. K. Latinis. The Washington manual rheumatology subspecialty consult , 2012 .
[9] C. Zouboulis,et al. [Epidemiology and clinical aspects of Adamantiades-Behçet disease in Gemany. Current data]. , 2012, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.
[10] O. Köse. Development of Immunopathogenesis Strategies to Treat Behçet's Disease , 2012, Pathology research international.
[11] S. Moretti,et al. Potential Infectious Etiology of Behçet's Disease , 2011, Pathology research international.
[12] A. Kokturk. Clinical and Pathological Manifestations with Differential Diagnosis in Behçet's Disease , 2011, Pathology research international.
[13] F. Davatchi. Diagnosis/Classification Criteria for Behcet's Disease , 2011, Pathology research international.
[14] M. Ustun,et al. Cerebral abscesses in Behcet's disease: a case report. , 2010, Turkish neurosurgery.
[15] O. Hiz,et al. Effects of Behçet's disease on sexual function and psychological status of male patients. , 2011, The journal of sexual medicine.
[16] F. Shahram,et al. Behcet’s disease: from east to west , 2010, Clinical Rheumatology.
[17] F. Gogus,et al. Prevalence of Behçet's syndrome in patients presenting with venous thrombosis: prospective study in a cardiovascular outpatient clinic , 2009 .
[18] L. Guillevin,et al. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. , 2009, Arthritis and rheumatism.
[19] W. Placek,et al. Case report Behçet disease – case report and review , 2009 .
[20] F. Shahram,et al. Colchicine versus placebo in Behçet’s disease: randomized, double-blind, controlled crossover trial , 2009, Modern rheumatology.
[21] P. Neri,et al. Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil , 2009, International Ophthalmology.
[22] J. Kempen,et al. Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. , 2008, American journal of ophthalmology.
[23] J. Coste,et al. Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration. , 2008, Arthritis and rheumatism.
[24] A. Silman,et al. EULAR recommendations for the management of Behçet disease , 2008, Annals of the rheumatic diseases.
[25] F. Shahram,et al. Prevalence of Behcet's disease in Iran: a WHO‐ILAR COPCORD stage I study , 2007 .
[26] G. Mumcu,et al. The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behçet's disease. , 2007, Clinical and experimental rheumatology.
[27] İ. Tuğal-Tutkun,et al. Pro-inflammatory cellular immune response in Behçet’s disease , 2007, Rheumatology International.
[28] B. Jaremin,et al. [Behçet's disease--diagnostic difficulties]. , 2007, Polskie Archiwum Medycyny Wewnetrznej.
[29] P. Martus,et al. Epidemiology and clinical manifestations of Adamantiades‐Behçet disease in Germany – Current pathogenetic concepts and therapeutic possibilities , 2006, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[30] M. Schirmer,et al. Major vessel involvement in Behçet disease , 2005, Current opinion in rheumatology.
[31] F. Shahram,et al. PULSE CYCLOPHOSPHAMIDE IN OCULAR MANIFESTATIONS OF BEHCET'S DISEASE: A DOUBLE BLIND CONTROLLED CROSSOVER STUDY , 2004 .
[32] H. Kikuchi,et al. Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years. , 2003, Advances in experimental medicine and biology.
[33] C. Ustün. A famous Turkish dermatologist, Dr. Hulusi Behçet. , 2002, European journal of dermatology : EJD.
[34] O. Ozcebe,et al. Behçet's disease. , 2019, The New England journal of medicine.
[35] G. Akman-Demir,et al. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group. , 1999, Brain : a journal of neurology.
[36] P. Jego. Le thalidomide dans le traitement des lésions cutanéomuqueuses de la maladie de Behçet. Une étude randomisée, à double insu, versus placebo , 1998 .
[37] S. Yamamoto,et al. Characterization of T cells specific for an epitope of human 60‐kD heat shock protein (hsp) in patients with Behçet's disease (BD) in Japan , 1997, Clinical and experimental immunology.
[38] Y. Tüzün,et al. Azathioprine in Behcet's syndrome: effects on long-term prognosis. , 1997, Arthritis and rheumatism.
[39] K. Hoshi,et al. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease. , 1992, The Journal of rheumatology.
[40] Calvin G. Barnes,et al. A controlled trial of azathioprine in Behçet's syndrome. , 1990, The New England journal of medicine.
[41] E. Atra,et al. [Behcet's syndrome]. , 1968, Revista paulista de medicina.
[42] E. Schulze. [Behçet disease]. , 1958, Deutsche medizinische Wochenschrift.